Janaushadhi Kendra and Its Impact on Pharma Market

GS Paper II

Context: With the expansion of Janaushadhi Kendra to more than 10,000 centers the pharma companies are facing losses.

Janaushadhi Kendra

Analysis on Generic Medicines and Its Impact on Pharma Industry

The rising penetration of generic medicine is denting the growth of the Rs 1.9 lakh-crore domestic pharma market.

Janaushadhi Kendras sell generic drugs that are priced 50 to 60 per cent lower than the popular brands.
Implemented by: Pharma & Medical Bureau of India (PMBI), Ministry of Chemicals and Fertilizers.
Social Benefits:
- Many of Janaushadhi stores are run by women entrepreneurs. Eg- Kerala.
Distribution: Currently, 33 percent of the stores are in South India.
- Uttar Pradesh has the highest number of Janaushadhi stores, at 1,481.
Drugs: Five out of the top 10 selling drugs at Janaushadhi kendras across India are related to diabetes and hypertension treatment.

Generic drugs are drugs with a similar composition as the branded drugs, but made once the patent ends.
India is primarily a branded generic drugs market, where several pharma companies sell their own brands of generic molecules
Low Cost: Trade generics are sold directly to hospitals and dispensaries. In the absence of marketing costs, the prices of non-branded generics are very low.

Continue To Read: Generic Medicines

News Source: BS